Bitget App
Mag-trade nang mas matalino
Buy cryptoMarketsTradeFuturesEarnSquareMore

RARE stock price forecast

How will RARE stock perform in 2026 and 2030?

This page primarily displays the projected price range for RARE stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of RARE, the development trends of Ultragenyx Pharmaceutical Inc., and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for RARE. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Ultragenyx Pharmaceutical Inc.'s financial performance and industry trends to provide short-term price predictions for RARE stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year RARE stock price forecast

Price target:
31.5 USD
+34.21%
Based on 1-year price forecasts from 59 analysts, the highest estimate is 42.55 USD, while the lowest estimate is 16.49 USD.

Analyst rating for RARE

Based on ratings from 60 analysts over the past three months, the overall consensus is Hold.

Strong buy
8
Buy
27
Hold
12
Sell
2
Strong sell
11

FAQ

How has RARE's EPS performed recently?

RARE's EPS is projected to reach -- USD next quarter. Explore more Ultragenyx Pharmaceutical Inc. financial data and stay up to date on the company's latest developments on the RARE stock details page.

What is the revenue forecast for RARE next quarter?

Ultragenyx Pharmaceutical Inc.'s revenue is projected to reach 198.60M USD USD in the next quarter. You can view Ultragenyx Pharmaceutical Inc.'s revenue and earnings on the RARE stock details page.

What is the price target for RARE?

Based on analyst estimates, the most likely target price for RARE over the next 12 months is 31.50 USD, with a projected high of 42.55 USD and a projected low of 16.49 USD. To track whether this target is reached within the next year, you can view the RARE stock price chart on the RARE stock details page to check the current RARE stock price, or follow the latest developments related to RARE on the RARE Stock News page.

What is the analyst rating for RARE?

We collected ratings from 60 analysts who have evaluated RARE stock over the past three months. Most analysts maintain a Hold outlook, and after aggregating all opinions, the overall consensus rating is Hold. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of RARE stock in 2030?

Based on price forecasts and analyses of Ultragenyx Pharmaceutical Inc. from Wall Street analysts and major investment banks, RARE is projected to trade between 46.94 USD and 234.70 USD in 2030.

RARE stock chart

RARE stock details

RARE stock price change

Sa huling araw ng trading, RARE sarado ang stock sa 23.47 USD, na may pagbabago sa presyo ng -3.02% para sa araw.

Trade stock futures

Tungkol kay Bitget

Ang unang Universal Exchange (UEX) sa mundo, na nagbibigay-daan sa mga gumagamit na mag-trade hindi lamang ng mga cryptocurrency, kundi pati na rin ng mga stock, ETF, forex, gold, at mga real-world asset (RWA).
Learn more
NASDAQ/
RARE stock price forecast